ICU Cell Saver to Reduce Blood Transfusions in Cardiac
Launched by CARDIOCHIRURGIA E.H. · Jul 30, 2009
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients presenting for cardiac Surgery
- Exclusion Criteria:
- • None
About Cardiochirurgia E.H.
Cardiochirurgia E.H. is a leading clinical trial sponsor specializing in innovative cardiovascular interventions and surgical techniques. Committed to advancing cardiac care, the organization conducts rigorous clinical research aimed at improving patient outcomes and enhancing the safety and efficacy of cardiovascular treatments. With a team of experienced professionals and a robust network of clinical sites, Cardiochirurgia E.H. fosters collaboration between researchers, healthcare providers, and patients, ensuring the highest standards of ethical conduct and scientific integrity in all its trials. Their dedication to excellence positions them at the forefront of cardiovascular research, contributing significantly to the evolving landscape of cardiac health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials